Asthma, chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria for asthmatic patients: (1) age 20-80 years; (2) paroxysmal wheezing, chest tightness, or cough; (3) Positive bronchial provocation test or bronchial dilation test of pulmonary function test; (4) those who signed the informed consent form. 2. Inclusion criteria of COPD patients: (1) age 20-80 years old; (2) wheezing, chest tightness and shortness of breath after activity; (3) history of smoking; (4) The results of pulmonary function test showed obstructive pulmonary ventilation dysfunction, and the bronchial dilation test was negative. (5) those who signed the informed consent form. 3. Inclusion criteria of controls: (1) age 20-80 years old; (2) No obvious lesions were found during physical examination due to pulmonary nodules or other reasons; (3) no symptoms of chest tightness or wheezing; (4) normal pulmonary function, negative bronchial provocation or dilation test; (5) those who signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Exclusion criteria for asthmatic patients: (1) combined with other respiratory diseases (such as bronchiectasis, lung cancer, interstitial lung disease, pneumonia, etc.); (2) diseases with abnormal immune function (such as systemic lupus erythematosus, AIDS, etc.); (3) patients with metabolic diseases (such as diabetes mellitus), liver diseases (such as cirrhosis), kidney diseases (such as uremia), and untreated chronic gastric ulcer with Helicobacter pylori infection; (4) Pregnancy. 2. Exclusion criteria of COPD patients: (1) complicated with other respiratory diseases (such as bronchiectasis, lung cancer, interstitial lung disease, pneumonia, etc.); (2) diseases with abnormal immune function (such as systemic lupus erythematosus, AIDS, etc.); (3) patients with metabolic diseases (such as diabetes mellitus), liver diseases (such as cirrhosis), kidney diseases (such as uremia), and untreated chronic gastric ulcer with Helicobacter pylori infection; (4) Pregnancy. 3. Exclusion criteria of controls: (1) patients with other respiratory diseases (such as asthma, COPD, bronchiectasis, respiratory tract infection, lung cancer, interstitial lung disease, pneumonia, etc.); (2) diseases with abnormal immune function (such as systemic lupus erythematosus, AIDS, etc.); (3) patients with metabolic diseases (such as diabetes mellitus), liver diseases (such as cirrhosis), kidney diseases (such as uremia), and untreated chronic gastric ulcer with Helicobacter pylori infection; (4) Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function + provocation test/relaxation test;Exhaled nitric oxide;Blood routine examination;Total IgE;CT Scan of the Lungs;Detection of allergens;ACT scores;CAT scores; | — |
Countries
China
Contacts
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology